Sutton Disease II

Links shared publicly online about this topic

Alzheimer's Disease Part II

alzheimersdisease02.blogspot.com — “Alzheimer's Disease Part IIView full resource at alzheimersdisease02.blogspot.com

  • View Related
  • Share

Most Recently Shared on October 10, 2011 at 12:12 am By:

kylejnorton Kyle J.Norton

Alzheimer's Disease Part II - What Causes Alzheimer's Disease? http://t.co/33A2NjVB

8 months ago...

Mucopolysaccharidosis Type II: eMedicine Pediatrics: Genetics and Metabolic Disease

emedicine.medscape.com — “Overview: Hunter syndrome, or mucopolysaccharidosis type II (MPS II), is a member of a group of inherited metabolic disorders collectively termed mucopolysaccharidoses (MPSs). The MPSs are caused by a deficiency of lysosomal enzymes required for the degradation ...View full resource at emedicine.medscape.com

  • View Related
  • Share

Most Recently Shared on July 15, 2009 at 9:36 pm By:

MedscapePeds Medscape Pediatrics Health Site and Pediatrics

Mucopolysaccharidosis Type II article over at eMedicine has been updated. http://bit.ly/VTYYW #genetics #pediatrics #health #medicine

3 years ago...

Phase II Study Of An Oral Therapy For Gaucher Disease Yields Positive Results

medicalnewstoday.com — “Gaucher disease, a rare enzyme deficiency disorder, is one of many conditions with few approved treatment options for patients. In aView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 5, 2010 at 12:18 pm By:

mnt_clinical MNT Clinical Trials Health News

Phase II Study Of An Oral Therapy For Gaucher Disease Yields Positive Results http://mnt.to/3C85 #clinicaltrials

2 years ago...

Can Social Networks Cure Disease? Part II

networkedblogs.com — “Can Social Networks Cure Disease? Part IIView full resource at networkedblogs.com

  • View Related
  • Share

Most Recently Shared on April 20, 2012 at 8:28 pm By:

The Pediatric Airway in Health and Disease II | VEOMED

veomed.com — “The Pediatric Airway in Health and Disease II | VEOMEDView full resource at veomed.com

  • View Related
  • Share

Most Recently Shared on March 15, 2010 at 10:39 pm By:

VeoMed VeoMed Team Medical Education

The Pediatric Airway in Health and Disease II by The Pediatric Emergency Medicine Resource Albany Medical College http://ow.ly/1lleV

2 years ago...

Glycogen Storage Disease, Type II (Pompe Disease): eMedicine Endocrinology

emedicine.medscape.com — “Overview: A glycogen storage disease (GSD) is the result of an enzyme defect. These enzymes normally catalyze reactions that ultimately convert glycogen compounds to monosaccharides, of which glucose is the predominant component. Enzyme deficiency results in glycogen ...View full resource at emedicine.medscape.com

  • View Related
  • Share

Most Recently Shared on May 5, 2010 at 7:01 pm By:

Health_SS Susan S Health Advocate

Type II glycogen storage disease, or Pompe disease, is a result of acid maltase deficiency. More about type II GSD. http://bit.ly/bQYTVx

2 years ago...

Launch Of First Phase II Trial Of Heart Disease Treatment For Duchenne Muscular Dystrophy

medicalnewstoday.com — “Kennedy Krieger Institute has announced the launch of a first-of-its-kind, phase II clinical trial to investigate a treatment for heart disease in individuals with Duchenne muscular dystrophy (DMView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on October 14, 2010 at 1:05 pm By:

mnt_menshealth MNT Men's Health Health News

Launch Of First Phase II Trial Of Heart Disease Treatment For Duchenne Muscular Dystrophy http://mnt.to/3L9R #menshealth

2 years ago...

A phase II trial of huperzine A in mild to moderate Alzheimer disease

neurology.org — “A phase II trial of huperzine A in mild to moderate Alzheimer diseaseView full resource at neurology.org

  • View Related
  • Share

Most Recently Shared on April 21, 2011 at 6:55 pm By:

GreenJournal Neurology Journal Medical Journal and Neurology

A phase II trial of huperzine A in mild to moderate Alzheimer disease http://bit.ly/gQ40CY #neurology

1 year ago...

Phase II study of an oral therapy for Gaucher disease yields positive results

physorg.com — “Gaucher disease, a rare enzyme deficiency disorder, is one of many conditions with few approved treatment options for patients. In a study published online today in Blood, the journal of the American Society of Hematology, researchers present positive results of a Phase II clinical trial of eliglustat ...View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on May 3, 2010 at 9:40 pm By:

physorg_health PhysOrg Health News Health News

Phase II study of an oral therapy for Gaucher disease yields positive results http://tw.physorg.com/192124667

2 years ago...

NeuroDerm Announces Positive Results Of A Phase II Study Of ND0611 Dermal Patch In Patients With Parkinson's Disease

medicalnewstoday.com — “NeuroDerm, Ltd. announced today the results of a Phase I/II safety and pharmacokinetic trial of ND0611, administered as an adjunct therapy to Sinemet®, Sinemet® CR or Stalevo®, in patiView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on November 10, 2011 at 11:05 am By:

mnt_parkinsons MNT Parkinson's News Health News

NeuroDerm Announces Positive Results Of A Phase II Study Of ND0611 Dermal Patch In Patients With Parkinson's Disease http://t.co/izZihbsC

7 months ago...

TxCell Receives Approval For Extension Of Phase I/II Clinical Trial In Crohn's Disease

medicalnewstoday.com — “TxCell SA, a biotechnology company developing cell-based immunotherapies for the treatment of severe chronic inflammatory diseases with high unmet medical need, announces today the approval by AFSView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 18, 2011 at 4:05 pm By:

mnt_crohns MNT Crohn's / IBD Health News

TxCell Receives Approval For Extension Of Phase I/II Clinical Trial In Crohn's Disease http://mnt.to/3W3D #crohns #ibd

1 year ago...

Symposier - Anatomic Basic of Echocardiography in Congenital Heart Disease-II

symposier.com — “Uploaded and Shared in Youtube by: ignousohs School of Health Sciences:Post Graduate Diploma in Clinical Cardiology (PGDCC):MCC-002 Fundamentals of Cardiovascular System-IIView full resource at symposier.com

  • View Related
  • Share

Most Recently Shared on March 4, 2010 at 3:37 am By:

Polyglandular Autoimmune Syndrome, Type II: eMedicine Endocrinology

emedicine.medscape.com — “Overview: Polyglandular autoimmune syndrome type II (PGA-II) is the most common of the immunoendocrinopathy syndromes. It is characterized by the obligatory occurrence of autoimmune Addison's disease in combination with thyroid autoimmune diseases and/or type 1 diabetes mellitus ...View full resource at emedicine.medscape.com

  • View Related
  • Share

Most Recently Shared on April 14, 2010 at 3:19 am By:

SusanS_Health Susan Scroggins Active Health Library and Health Advocate

Polyglandular autoimmune syndrome type 2 is characterized by Addison's disease plus thyroid autoimmune disease...http://bit.ly/dhsev0

2 years ago...

ThromboGenics Positive Microplasmin Phase II Data Published In Ophthalmology

medicalnewstoday.com — “ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces thaView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on February 10, 2010 at 3:09 pm By:

mnt_eyehealth MNT Eye Health Health News

ThromboGenics Positive Microplasmin Phase II Data Published In Ophthalmology http://mnt.to/3xrc #eyehealth

2 years ago...

Angiotensin II Antagonists In Paroxysmal Atrial Fibrillation, Results From The ANTIPAF Trial

medicalnewstoday.com — “Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting about 7 million people in Europe. It is a progressive chronic disease in which episodes become more frequent and long-lastView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on September 1, 2010 at 11:40 am By:

hrana Hisham Rana, MD Doctor and Physician

News: Angiotensin II antagonists in paroxysmal atrial fibrillation, results from the ANTIPAF trial http://bit.ly/dnPNNg - #health

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390